The role of therapy in impairing quality of life in dermatological patients a multinational study /
Skin disease and its therapy affect health-related quality of life (HRQoL). The aim of this study was to measure the burden caused by dermatological therapy in 3,846 patients from 13 European countries. Adult outpatients completed questionnaires, including the Dermatology Life Quality Index (DLQI),...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2018
|
| Sorozat: | ACTA DERMATO-VENEREOLOGICA
98 No. 6 |
| doi: | 10.2340/00015555-2918 |
| mtmt: | 3370301 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/13735 |
| LEADER | 02378nab a2200373 i 4500 | ||
|---|---|---|---|
| 001 | publ13735 | ||
| 005 | 20180821123439.0 | ||
| 008 | 180821s2018 hu o 0|| zxx d | ||
| 022 | |a 0001-5555 | ||
| 024 | 7 | |a 10.2340/00015555-2918 |2 doi | |
| 024 | 7 | |a 3370301 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Balieva Flora N. | |
| 245 | 1 | 4 | |a The role of therapy in impairing quality of life in dermatological patients |h [elektronikus dokumentum] : |b a multinational study / |c Balieva Flora N. |
| 260 | |c 2018 | ||
| 300 | |a 563-569 | ||
| 490 | 0 | |a ACTA DERMATO-VENEREOLOGICA |v 98 No. 6 | |
| 520 | 3 | |a Skin disease and its therapy affect health-related quality of life (HRQoL). The aim of this study was to measure the burden caused by dermatological therapy in 3,846 patients from 13 European countries. Adult outpatients completed questionnaires, including the Dermatology Life Quality Index (DLQI), which has a therapy impact question. Therapy issues were reported by a majority of patients with atopic dermatitis (63.4%), psoriasis (60.7%), prurigo (54.4%), hidradenitis suppurativa (54.3%) and blistering conditions (53%). The largest reduction in HRQoL attributable to therapy, as a percentage of total DLQI, adjusted for confounders, was seen in blistering conditions (10.7%), allergic/drug reactions (10.2%), psoriasis (9.9%), vasculitis/immunological ulcers (8.8%), atopic dermatitis (8.7%), and venous leg ulcers (8.5%). In skin cancer, although it had less impact on HRQoL, the reduction due to therapy was 6.8%. Treatment for skin disease contributes considerably to reducing HRQoL: the burden of dermatological treatment should be considered when planning therapy and designing new dermatological therapies. | |
| 700 | 0 | 1 | |a Finlay Andrew Y. |e aut |
| 700 | 0 | 1 | |a Kupfer Jörg |e aut |
| 700 | 0 | 2 | |a Tomas Aragones Lucia |e aut |
| 700 | 0 | 2 | |a Lien Lars |e aut |
| 700 | 0 | 2 | |a Gieler Uwe |e aut |
| 700 | 0 | 2 | |a Poot Francoise |e aut |
| 700 | 0 | 2 | |a Misery Laurent |e aut |
| 700 | 0 | 2 | |a Kemény Lajos |e aut |
| 700 | 0 | 2 | |a Sampogna Francesca |e aut |
| 700 | 0 | 2 | |a Van Middendorp Henriët |e aut |
| 700 | 0 | 2 | |a Halvorsen John Anders |e aut |
| 700 | 0 | 2 | |a Ternowitz Thomas |e aut |
| 700 | 0 | 2 | |a Szepietowski Jacek C. |e aut |
| 700 | 0 | 2 | |a Potekaev Nikolay |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/13735/1/3370301_Balieva_2018_ADV_u.pdf |z Dokumentum-elérés |